RALEIGH, N.C., March 9 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Joe Dillon has joined its Business Development Practice. Mr. Dillon will work closely with the Business Development Practice to help pharmaceutical and biotech clients address business challenges and develop comprehensive strategies related to in- and out-licensing, opportunity assessment, and overall business development strategy.
Mr. Dillon has more than twenty years of experience in the pharmaceutical industry. Most recently, he was the Senior Vice President and Head of Corporate Development and Valuations at the Mattson Jack Group. In this role, Mr. Dillon was responsible for designing and developing valuation, risk assessment, and deal structuring systems, as well as improving the business development partnering process. He has also been a regular speaker at many pharmaceutical-related conferences throughout the US and Europe.
"Joe has extensive expertise in business development strategy and knowledge of commercializing products. This combination of skills, coupled with his long-standing industry experience, will be a valuable asset to our firm and to the pharmaceutical and biotech clients that depend on our services," said John Campbell, CEO of Campbell Alliance.
Prior to his role at Mattson Jack, Mr. Dillon was Principal at Dillon Technologies, an executive consulting firm based in Tampa, FL. In this role, he provided management and financial consulting services to firms in challenging situations. Providing interim executive management, he served as President and CEO of Pharmaceutical Development Center, a pharmaceutical manufacturer and development company. Mr. Dillon has also held leadership positions with Oread, Inc., a pharmaceutical manufacturer and development company, and with Hoechst Marion Roussel, a multi-billion dollar pharmaceutical company and predecessor company of Sanofi-Aventis.
Mr. Dillon graduated with a BA in Business Administration with honors from
About the Business Development Practice at Campbell Alliance
The Business Development Practice at Campbell Alliance helps pharmaceutical licensing executives achieve an edge over the competition. Our consultants provide experienced counsel to clients who need assistance developing BD strategies, identifying partners, prioritizing targets, evaluating opportunities, and negotiating deals.
The firm's team includes seasoned consultants and industry professionals in pharmaceutical and biotech BD who have identified, assessed, and executed numerous in-licensing deals. They have also been valuable in aiding out-licensors, helping clients improve internal processes for pharmaceutical business development, and assisting top executives in charting new strategies in corporate development.
About Campbell Alliance
Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.
CONTACT: James Forte Director, Public and Media Relations Campbell Alliance 919-844-7100, extension 7195 firstname.lastname@example.org
|SOURCE Campbell Alliance|
Copyright©2009 PR Newswire.
All rights reserved